Back to Search Start Over

What are the effects of mepolizumab for adults with relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA)?

Authors :
Sera Tort
Raouf Hajji
Source :
Cochrane Clinical Answers.
Publication Year :
2020
Publisher :
Wiley, 2020.

Subjects

Subjects :
medicine.medical_specialty
Refractory
business.industry
Eosinophilic
medicine
General Medicine
Granulomatosis with polyangiitis
medicine.disease
business
Dermatology
Mepolizumab
medicine.drug

Details

ISSN :
20504217
Database :
OpenAIRE
Journal :
Cochrane Clinical Answers
Accession number :
edsair.doi...........8f7667d0a620073d208c8ab5290f458d
Full Text :
https://doi.org/10.1002/cca.3380
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details